Previous Page  784-785 / 2351 Next Page
Information
Show Menu
Previous Page 784-785 / 2351 Next Page
Page Background

Role of adjuvant

Cis‐FU

Hong Kong trial

( 508)

n=

Weekly cisplatin 40 mg/m2

+postirr. adjuvant chemotherapy 3 cycles

- cisplatin (80 mg/m2) and 5-FU (800 mg/m2/day for 120h)

Chen et al. Lancet Oncology 2012; 13:163-171.